Carbohydrate–protein interactions are involved in various intracellular functions and play an essential role in biological system, particularly at the level of cell–cell recognition, cell adhesion, and cell signaling processes. The importance of carbohydrate–protein binding is now recognized as a major mode of interaction between microbial pathogens and animal cells. Using innovative synthetic methods for oligosaccharide assembly an increasing number of synthetic carbohydrates of biomedical importance is available. Here, we illustrate using some case studies that show the design and the use of a glycosylphosphatidylinositol oligosaccharide library. We discuss the importance of parasite glycosylphosphatidylinositol–protein interactions including receptors, enzymes, and antibodies. Furthermore, glycosylphosphatidylinositol epitope mapping studies are of interest in the field of parasitic diseases, and provide a promising platform to understand structure–function relationships of glycosylphosphatidylinositols.
Get full access to this article
View all access options for this article.
References
1.
AlaviA., AxfordJ.S.2008. Sweet and sour: the impact of sugars on disease. Rhematology (Oxford), 47:760–770.
AxfordJ.2001. The impact of glycobiology on medicine. Trends Immunol, 22:237–239.
4.
AzzouzN., Shams-EldinH., SchwarzR.T.2005. Removal of phospholipid contaminants through precipitation of glycosylphosphatidylinositols. Anal Biochem, 343:152–158.
5.
AzzouzN., Shams-EldinH., NiehusS., Debierre-GrockiegoF., BiekerU., SchmidtJ.et al.2006. Toxoplasma gondii grown in human cells uses GalNAc-containing glycosylphosphatidylinositol precursors to anchor surface antigens while the immunogenic Glc-GalNAc-containing precursors remain free at the parasite cell surface. Int J Biochem Cell Biol, 38:1914–1925.
BerheS., SchofieldL., SchwarzR.T., GeroldP.1999. Conservation of structure among glycosylphosphatidylinositol toxins from different geographic isolates of Plasmodium falciparum. Mol Biochem Parasitol, 103:273–278.
8.
BoonyarattanakalinS., LiuX., MichielettiM., LepeniesB., SeebergerP.H.2008. Chemical synthesis of all phosphatidylinositol mannoside (PIM) glycans from Mycobacterium tuberculosis. J Am Chem Soc, 130:16791–16799.
9.
ChangT., MilneK.G., GütherM.L., SmithT.K., FergusonM.A.2002. Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite. J Biol Chem, 277:50176–50182.
10.
ChtanovaT., HanS.J., SchaefferM., van DoorenG.G., HerzmarkP., StriepenB.et al.2009. Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity, 31:342–355.
11.
DellA., MorrisH.R., EastonR.L., PatankarM., ClarkG.F.1999. The glycobiology of gametes and fertilization. Biochim Biophys Acta, 1473:196–205.
12.
DelorenziM., SextonA., Shams-EldinH., SchwarzR.T., SpeedT., SchofieldL.2002. Genes for glycosylphosphatidylinositol toxin biosynthesis in Plasmodium falciparum. Infect Immun, 70:4510–4522.
13.
de MacedoC.S., Shams-EldinH., SmithT.K., SchwarzR.T., AzzouzN.2003. Inhibitors of glycosyl-phosphatidylinositol anchor biosynthesis. Biochimie, 85:465–472.
14.
de PazJ.L., SeebergerP.H.2008. Deciphering the glycosaminoglycan code with the help of microarrays. Mol Biosyst, 4:707–711.
15.
DoddR.B., DrickmerK.2001. Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity. Glycobiology, 11:71R–79R.
16.
DubeD.H., BertozziC.R.2005. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov Nat Rev Drug Discov, 4:477–488.
17.
EisenhaberB., Maurer-StrohS., NovatchkovaM., SchneiderG., EisenhaberF.2003. Enzymes and auxiliary factors for GPI lipid anchor biosynthesis and post-translational transfer to proteins. BioEssays, 4:367–385.
18.
FergusonM.A.1999. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci, 112:2799–2809.
19.
FergusonM.A., BrimacombeJ.S., BrownJ.R., CrossmanA., DixA., FieldR.A.et al.1999. The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim Biophys Acta, 1455:327–340.
20.
FreezeH.H., AebiM.2005. Altered glycan structures: the molecular basis of congenital disorders of glycosylation. Curr Opin Struct Biol, 15:490–498.
21.
FujitaM., JigamiY.2008. Lipid remodeling of GPI-anchored proteins and its function. Biochem Biophys Acta, 1780:410–420.
22.
FukudaM.N., AkamaT.O.2003. The role of N-glycans in spermatogenesis. Cytogenet Genome Res, 103:302–306.
23.
FusterM.M., EskoJ.D.2005. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 2005, 5:526–542.
24.
GagneuxP., VarkiA.1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiolgy, 9:747–755.
25.
HorlacherT., SeebergerP.H.2008. Carbohydrate arrays as tools for research and diagnostics. Chem Soc Rev, 37:1414–1422.
26.
HongY., KinoshitaT.2009. Trypanosome glycosylphosphatidylinositol Biosynthesis. Korean J Parasitol, 47:197–204.
InoueN., Izui-SarumaruT., MurakamiY., EndoY., NishimuraJ.I., KurokawaK.et al.2006. Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)Blood, 108:4232–4236.
31.
JaekenJ., MatthijsG.2007. Congenital disorders of glycosylation: a rapidly expanding disease family. Annu Rev Genomics Hum Genet, 8:261–278.
32.
KamenaF., TamborriniM., LiuX., KwonY.U., ThompsonF., PluschkeG.et al.2008. Synthetic GPI array to study antitoxic malaria response. Nat Chem Biol, 4:238–240.
33.
KinoshitaK., InoueN.2000. Dissecting and manipulating the pathway for glycosylphosphatidylinositol-anchor biosynthesis. Curr Opin Chem Biol, 4:632–638.
34.
KinoshitaT., FujitaM., MaedaY.2008. Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress. J Biochem, 144:287–294.
35.
KobataA.2000. A journey to the world of glycobiology. Glycoconj J, 17:443–464.
36.
KravetzJ.D., FedermanD.G.2005. Toxoplasmosis in pregnancy. Am J Med, 118:212–216.
37.
KrishnamoorthyL., MahalL.K.2009. Glycomic analysis: an array of technologies. ACS Chem Biol, 4:715–732.
38.
KwonY.U., SoucyR.L., SnyderD.A., SeebergerP.H.2005. Assembly of a series of malarial glycosylphosphatidylinositol anchor oligosaccharides. Chem Eur J, 11:2493–2504.
39.
LarsenK., ThygesenM.B., GuillaumieF., WillatsW.G., JensenK.J.2006. Solid-phase chemical tools for glycobiology. Carbohydr Res 2006, 341:1209–1234.
40.
LauK.S., DenisJ.W.2008. N-Glycans in cancer progression. Glycobiology, 18:750–760.
41.
LekutisC., FergusonD.J., GriggM.E., CampsM., BoothroydJ.C.2001. Surface antigens of Toxoplasma gondii: variations on a theme. Int J Parasitol, 31:1285–1292.
42.
LeyK., KansasG.S.2004. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol, 4:325–335.
43.
LimJ., GowdaD.C., KrishnegowdaG., LuckhartS.2005. Induction of nitric oxide synthase in Anopheles stephensi by Plasmodium falciparum: mechanism of signaling and the role of parasite glycosylphosphatidylinositols. Infect Immun, 73:2778–2789.
MagezS., StijlemansB., RadwanskaM., PaysE., FergusonM.A.J., De BaetselierP.1998. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J Immunol, 160:1949–1956.
48.
McConvilleM.J., MenonA.K.2000. Recent developments in the cell biology and biochemistry of glycosylphosphatidylinositol lipids. Mol Membr Biol, 17:1–16.
NaikR.S., BranchO.H., WoodsA.S., VijaykumarM., PerkinsD.J., NahlenB.L.et al.2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med, 192:1563–1576.
51.
OppenheimerS.B., AlvarezM., NnoliJ.2008. Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseases. Acta Histochem Acta Histochem, 110:6–13.
52.
OrleanP., MenonA.K.2007. Thematic review series: lipid posttranslational modifactions. GPI anchoring of protein in yeast in mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J Lipid Res, 48:993–1011.
53.
OyelaranO., GildersleeveJ.C.2007. Application of carbohydrate array technology to antigen discovery and vaccine development. Expert Rev Vaccines, 6:957–969.
54.
OyelaranO., McShaneL.M., DoddL., GildersleeveJ.C.2009a. Profiling human serum antibodies with a carbohydrate antigen microarray. J Proteome Res, 8:4301–4310.
PaulickM.G., BertozziC.R.2008. The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry, 47:6991–7000.
57.
PlanteO.J., AndradeR.B., SeebergerP.H.1999. Synthesis and use of glycosyl phosphates as glycosyl donors. Org Lett, 1:211–214.
58.
PlanteO.J., PalmacciE.R., AndradeR.B., SeebergerP.H.2001. Oligosaccharide synthesis with glycosyl phosphate and dithiophosphate triesters as glycosylating agents. J Am Chem Soc, 123:9545–9554.
59.
PowellA.K., ZhiZ.L., TurnbullJ.E.2009. Saccharide microarrays for high-throughput interrogation of glycan-protein binding interactions. Methods Mol Biol, 534:313–329.
60.
Reevan R. 2002. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol, 129:189–197.
61.
RobinsonP.J.1991. Signal transduction by GPI-anchored membrane proteins. Cell Biol Intern Rep, 15:761–767.
62.
RosemanS.2001. Reflections on glycobiology. J Biol Chem, 276:41527–41542.
63.
RuddP.M., ElliottT., CresswellP., WilsonI.A., DwekR.A.2001. Glycosylation and the immune system. Science, 291:2370–2376.
64.
RuddP.M., WormaldM.R., DwekR.A.2004. Sugar-mediated ligand–receptor interactions in the immune system. Trends Biotechnol, 22:524–530.
65.
SchmidtA., SchwarzR.T., GeroldP.1998. Plasmodium falciparum: asexual erythrocytic stages synthesize two structurally distinct free and protein-bound glycosylphosphatidylinositols in a maturation-dependent manner. Exp Parasitol, 88:95–102.
66.
SchmidtR.R.1986. New methods for the synthesis of glycosides and oligosaccharides. Are there alternatives to the Koenigs-Knorr method?Angew Chem Int Ed Engl, 25:212–235.
67.
SchmidtR.R., MichelJ.1980. Facile synthesis of R- and β-O-glycosyl imidates; preparation of glycosides and disaccharides. Angew Chem Int Ed Engl, 19:731–732.
SchofieldL., HackettF.1993. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med, 177:145–153.
72.
SchofieldL., TachadoS.D.1996. Regulation of host cell function by glycosylphosphatidylinositols of parasitic protozoa. Immunol Cell Biol, 74:555–563.
73.
SchofieldL., NovakovicS., GeroldP., SchwarzR.T., McConvilleM.J., TachadoS.D.1996. Glycosylphosphatidylinositol toxin of Plasmodium falciparum up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte kinase-dependent signal transduction. J Immunol, 156:1886–1896.
74.
SchofieldL., HewittM.C., EvansK., SiomosM.-A., SeebergerP.H.2002. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature, 418:785–789.
75.
SeebergerP.H., WerzD.B.2005. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat Rev Drug Discov, 4:751–763.
76.
SeebergerP.H., WerzD.B.2007. Synthesis and medical applications of oligosaccharides. Nature, 446:1046–1051.
77.
SmithT.K., MilneF.C., SharmaD.K., CrossmanA., BrimacombeJ.S., FergusonM.A.1997a. Early steps in glycosylphosphatidylinositol biosynthesis in Leishmania major. Biochem J, 326:393–400.
78.
SmithT.K., SharmaD.K., CrossmanA., DixA., BrimacombeJ.S., FergusonM.A.1997b. Parasite and mammalian GPI biosynthetic pathways can be distinguished using synthetic substrate analogues. EMBO J, 16:6667–6675.
79.
SmithT.K., SharmaD.K., CrossmanA., BrimacombeJ.S., FergusonM.A.1999. Selective inhibitors of the glycosylphosphatidylinositol biosynthetic pathway of Trypanosoma brucei. EMBO J, 18:5922–5930.
80.
SmithT.K., GeroldP., CrossmanA., PatersonM.J., BorissowC.N., BrimacombeJ.S.et al.2002. Substrate specificity of the Plasmodium falciparum glycosylphosphatidylinositol biosynthetic pathway and inhibition by species-specific suicide substrates. Biochemistry, 41:12395–12406.
81.
SmithT.K., CrossmanA., BrimacombeJ.S., FergusonM.A.2004. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. EMBO J, 23:4701–4708.
82.
SpringerT.A., LaskyL.A.1991. Cell adhesion. Sticky sugars for selectins. Nature, 349:196–197.
83.
StallforthP., LepeniesB., AdibekianA., SeebergerP.H.2009. Claude S. Hudson Award in carbohydrate chemistry. Carbohydrates: a frontier in medicinal chemistry. J Med Chem, 52:5561–5577.
84.
SvarovskyS.A., JoshiL.2008. Biocombinatorial selection of carbohydrate binding agents of therapeutic significance. Curr Drug Discov Technol, 5:20–28.
85.
TachadoS.D., SchofieldL.1994. Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem Biophys Res Commun, 205:984–991.
86.
TachadoS.D., GeroldP., McConvilleM.J., BaldwinM.J., QuiliciD., SchwarzR.T.et al.1996. Glycosylphosphatidylinositol toxin of Plasmodium falciparum induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol, 156:1897–1907.
87.
TachadoS.D., GeroldP., SchwarzR.T., NovakovicS., McConvilleM.J., SchofieldL.1997. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci USA, 94:4022–4027.
88.
TachadoS.D., Mazhari-TabriziR., SchofieldL.1999. Specificity in signal transduction among glycosylphosphatidylinositols of Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. Parasite Immunol, 12:609–617.
89.
TiedeA., BastischI., SchubertJ., OrleanP., SchmidtR. E.1999. Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol Chem, 380:503–523.
90.
UrbaniakM.D., YashunskyD.V., CrossmanA., NikolaevA.V., FergusonM.A.2008. Probing enzymes late in the trypanosomal glycosylphosphatidylinositol biosynthetic pathway with synthetic glycosylphosphatidylinositol analogues. ACS Chem Biol, 3:625–634.
91.
UttamchandaniM., NeoJ.L., OngB.N., MoochhalaS.2009. Applications of microarrays in pathogen detection and biodefence. Trends Biotechnol, 27:53–61.
92.
von ItzsteinM.2008. Disease-associated carbohydrate-recognising proteins and structure-based inhibitor design. Curr Opin Struct Biol, 18:558–566.
93.
von ItzsteinM., PlebanskiM., CookeB.M., CoppelR.L.2008. Hot, sweet and sticky: the glycobiology of Plasmodium falciparum. Trends Parasitol, 24:210–218.
94.
WichroskiM.J., WardG.E.2003. Biosynthesis of glycosylphosphatidylinositol is essential to the survival of the protozoan parasite Toxoplasma gondii. Eukaryot Cell, 2:1132–1136.
95.
WuQ., GuoZ.2009. Glycosylphosphatidylinositols are potential targets for the development of novel inhibitors for aerolysin-type of pore-forming bacterial toxins. Med Res Rev(in press).
96.
XuG., LamK.S.2003. Protein and chemical microarrays-powerful tools for proteomics. J Biomed Biotechnol, 2003:257–266.
97.
ZhangH., MaY., SunX.L.2009. Recent developments in carbohydrate-decorated targeted drug/gene delivery. Med Res Rev(in press).
